Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008

M. C F Prosperi; A. Cozzi-Lepri; A. Antinori; G. Cassola; C. Torti; M. A. Ursitti; G. P. Pellizzer; A. Giacometti; A. D'Arminio Monforte; A. De Luca

doi:10.1111/j.1468-1293.2010.00866.x

Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008

M. C F Prosperi, A. Cozzi-Lepri, A. Antinori, G. Cassola, C. Torti, M. A. Ursitti, G. P. Pellizzer, A. Giacometti, A. D'Arminio Monforte, A. De Luca

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Research output: Contribution to journal › Article › peer-review

Abstract

Background: This study provides an estimate of the proportion of HIV-positive patients in Italian clinics showing an 'adverse prognosis' (defined as a CD4 count ≤200cells/μL or an HIV RNA >50 HIV-1 RNA copies/mL) over time, and investigates whether this proportion varied according to patients' characteristics. Methods: We estimated the annual proportion of patients with a CD4 count ≤200cells/μL or HIV RNA >50copies/mL out of the total number of patients in the Icona Foundation cohort seen in any given year, both overall and after stratifying by demographical and treatment status groups. Generalized estimating equation models for Poisson regression were applied. Results: In 1998-2008, the prevalence of patients with a CD4 count ≤200cells/μL decreased from 14 to 6% [adjusted relative risk (RR) 0.86/year; 95% confidence interval (CI) 0.84-0.88; P50copies/mL decreased from 66 to 40% (adjusted RR 0.95/year; 95% CI 0.95-0.96; P

Original language	English
Pages (from-to)	174-182
Number of pages	9
Journal	HIV Medicine
Volume	12
Issue number	3
DOIs	https://doi.org/10.1111/j.1468-1293.2010.00866.x
Publication status	Published - Mar 2011

Keywords

HIV-1
Immunological response rates
Poisson regression
Virological response rates

ASJC Scopus subject areas

Infectious Diseases
Pharmacology (medical)
Health Policy

Access to Document

10.1111/j.1468-1293.2010.00866.x

Cite this

Prosperi, M. C. F., Cozzi-Lepri, A., Antinori, A., Cassola, G., Torti, C., Ursitti, M. A., Pellizzer, G. P., Giacometti, A., D'Arminio Monforte, A., & De Luca, A. (2011). Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008. HIV Medicine, 12(3), 174-182. https://doi.org/10.1111/j.1468-1293.2010.00866.x

Prosperi, MCF, Cozzi-Lepri, A, Antinori, A, Cassola, G, Torti, C, Ursitti, MA, Pellizzer, GP, Giacometti, A, D'Arminio Monforte, A & De Luca, A 2011, 'Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008', HIV Medicine, vol. 12, no. 3, pp. 174-182. https://doi.org/10.1111/j.1468-1293.2010.00866.x

@article{bdaa636c63ab42f4b75742241d7e4914,

title = "Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008",

abstract = "Background: This study provides an estimate of the proportion of HIV-positive patients in Italian clinics showing an 'adverse prognosis' (defined as a CD4 count ≤200cells/μL or an HIV RNA >50 HIV-1 RNA copies/mL) over time, and investigates whether this proportion varied according to patients' characteristics. Methods: We estimated the annual proportion of patients with a CD4 count ≤200cells/μL or HIV RNA >50copies/mL out of the total number of patients in the Icona Foundation cohort seen in any given year, both overall and after stratifying by demographical and treatment status groups. Generalized estimating equation models for Poisson regression were applied. Results: In 1998-2008, the prevalence of patients with a CD4 count ≤200cells/μL decreased from 14 to 6% [adjusted relative risk (RR) 0.86/year; 95% confidence interval (CI) 0.84-0.88; P50copies/mL decreased from 66 to 40% (adjusted RR 0.95/year; 95% CI 0.95-0.96; P",

keywords = "HIV-1, Immunological response rates, Poisson regression, Virological response rates",

author = "Prosperi, {M. C F} and A. Cozzi-Lepri and A. Antinori and G. Cassola and C. Torti and Ursitti, {M. A.} and Pellizzer, {G. P.} and A. Giacometti and {D'Arminio Monforte}, A. and {De Luca}, A.",

year = "2011",

month = mar,

doi = "10.1111/j.1468-1293.2010.00866.x",

language = "English",

volume = "12",

pages = "174--182",

journal = "HIV Medicine",

issn = "1464-2662",

publisher = "Blackwell Publishing Ltd",

number = "3",

}

TY - JOUR

T1 - Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008

AU - Prosperi, M. C F

AU - Cozzi-Lepri, A.

AU - Antinori, A.

AU - Cassola, G.

AU - Torti, C.

AU - Ursitti, M. A.

AU - Pellizzer, G. P.

AU - Giacometti, A.

AU - D'Arminio Monforte, A.

AU - De Luca, A.

PY - 2011/3

Y1 - 2011/3

N2 - Background: This study provides an estimate of the proportion of HIV-positive patients in Italian clinics showing an 'adverse prognosis' (defined as a CD4 count ≤200cells/μL or an HIV RNA >50 HIV-1 RNA copies/mL) over time, and investigates whether this proportion varied according to patients' characteristics. Methods: We estimated the annual proportion of patients with a CD4 count ≤200cells/μL or HIV RNA >50copies/mL out of the total number of patients in the Icona Foundation cohort seen in any given year, both overall and after stratifying by demographical and treatment status groups. Generalized estimating equation models for Poisson regression were applied. Results: In 1998-2008, the prevalence of patients with a CD4 count ≤200cells/μL decreased from 14 to 6% [adjusted relative risk (RR) 0.86/year; 95% confidence interval (CI) 0.84-0.88; P50copies/mL decreased from 66 to 40% (adjusted RR 0.95/year; 95% CI 0.95-0.96; P

AB - Background: This study provides an estimate of the proportion of HIV-positive patients in Italian clinics showing an 'adverse prognosis' (defined as a CD4 count ≤200cells/μL or an HIV RNA >50 HIV-1 RNA copies/mL) over time, and investigates whether this proportion varied according to patients' characteristics. Methods: We estimated the annual proportion of patients with a CD4 count ≤200cells/μL or HIV RNA >50copies/mL out of the total number of patients in the Icona Foundation cohort seen in any given year, both overall and after stratifying by demographical and treatment status groups. Generalized estimating equation models for Poisson regression were applied. Results: In 1998-2008, the prevalence of patients with a CD4 count ≤200cells/μL decreased from 14 to 6% [adjusted relative risk (RR) 0.86/year; 95% confidence interval (CI) 0.84-0.88; P50copies/mL decreased from 66 to 40% (adjusted RR 0.95/year; 95% CI 0.95-0.96; P

KW - HIV-1

KW - Immunological response rates

KW - Poisson regression

KW - Virological response rates

UR - http://www.scopus.com/inward/record.url?scp=79551595138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551595138&partnerID=8YFLogxK

U2 - 10.1111/j.1468-1293.2010.00866.x

DO - 10.1111/j.1468-1293.2010.00866.x

M3 - Article

C2 - 20726904

AN - SCOPUS:79551595138

VL - 12

SP - 174

EP - 182

JO - HIV Medicine

JF - HIV Medicine

SN - 1464-2662

IS - 3

ER -

Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this